A detailed history of Verdence Capital Advisors LLC transactions in Absci Corp stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 14,060 shares of ABSI stock, worth $81,829. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,060
Holding current value
$81,829
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$2.55 - $4.38 $35,853 - $61,582
14,060 New
14,060 $36,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $540M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.